Phase III Confirmatory Study in Erythropoietic Protoporphyria

Clinical trial NCT01605136 · COMPLETED

Trial details

NCT number: NCT01605136
Sponsor: Clinuvel Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria

Start date: 2012-05-01
Primary completion: 2013-07-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.